Weathering the pandemic has necessitated levels of resilience and collaboration that are unmatched in most of our lifetimes. Though we continue to face disruption and challenges, Oracle and its employees remain steadfast and strong, stepping up to support our communities, colleagues, and customers.
Recording health information on vaccinations and disease treatments can help save lives. By working together with the Tony Blair Institute for Global Change, Oracle is providing three African nations—Ghana, Rwanda, and Sierra Leone—with a modern, cloud-based, electronic health records system to help them manage their large-scale vaccination programs, contain major diseases, and save lives. The ten-year commitment will provide free access to the Oracle Health Management system, which will also support COVID-19 vaccine rollouts.
The impact of the COVID-19 outbreak has been immense on all fronts—economic, societal, and humanitarian. Through our philanthropy, we’re helping our grantees focus their resources and services where they’re needed most. In India, we donated more than US$6.8 million to nonprofit organizations providing immediate relief and rehabilitation to migrant workers, women, and children.
We continue to support effective nonprofit organizations advancing education, protecting the environment, and strengthening communities in other parts of the world, including in the US, Japan, Kenya, Nigeria, and across Latin America. Many of our grantees have stepped up to support vulnerable populations that are disproportionately impacted by the pandemic.
Whether on Zoom, on the phone, or through offline, self-paced projects, volunteering is evolving and adapting. Through acts of kindness large and small, Oracle Volunteers have found new ways to make a difference in their communities.
Additionally, employees have donated millions of dollars to nonprofit organizations globally in the fight against COVID-19. Together with the company match, employees donated more than US$1 million to support COVID-19 relief efforts from March through May 2020.
Oracle customers, partners, startups, and research collaborators are on the frontlines of the fight against the pandemic. Oracle has joined forces with hospitals, governments, research institutions, essential businesses, and others to meet new challenges.
More than 1,000 employees helped build the Therapeutic Learning System, a technology solution to aid doctors in determining which drugs are effective in treating or preventing infection. The Therapeutic Learning System was deployed on March 30, 2020, and is the result of a unique and significant collaboration with US agencies including the National Institutes of Health, Food and Drug Administration, Centers for Disease Control and Prevention, Centers for Medicare & Medicaid Services, and the Department of Health and Human Services.
Oracle for Startups stepped up to help startups during the pandemic and quickly witnessed how startups in turn helped others, from making their solutions free to pursuing COVID-19 treatments. Oracle for Research worked with researchers to predict the spread of the virus and accelerate drug and vaccine discovery, with fast access to high performance computing, artificial intelligence, and technical advising. And across the globe, Oracle employees supported COVID-related projects proposed by their customers and partners.
Throughout the pandemic, data and the tools to understand and use it have been essential to fight the virus, keep businesses and economies open, and connect people. To date, Oracle has donated millions of dollars of Oracle Cloud resources to support COVID-related projects from contact tracing to developing effective vaccines.
Reliable data was critical for the University of Wyoming and Baylor University as they shifted gears quickly when the pandemic hit.
The city of Atlanta, Lucas County in Ohio, and New York State all use cloud technology to help manage the impact of COVID-19.
The Australian institution used cloud-based resources to screen hundreds of thousands of drug compounds to quickly short-list candidates for efficacy against the COVID-19 virus.
Drug researchers use GridMarkets’ high-performance rendering platform to simulate molecular reactions to COVID-19.
Researchers at LNBio, the Brazilian Biosciences National Laboratory, are using high performance computing to evaluate whether existing drugs can be repurposed in the fight against COVID-19.
NI’s COVID-19 crisis team is making fact-based decisions about facilities reopenings and employee safety protocols with the insights they’re getting from analytics.
Oracle teams helped Oklahoma’s newly home-based workers get productive as quickly as possible by designing and deploying a chatbot to help them continue to provide critical constituent services.
Researchers at the University of Bristol’s School of Biochemistry used high performance computing to help them visualize and study the virus at the cellular level.